Suppr超能文献

利福平药物相互作用的最新进展,III。

Update on rifampin drug interactions, III.

作者信息

Strayhorn V A, Baciewicz A M, Self T H

机构信息

Department of Clinical Pharmacy, University of Tennessee, Memphis, USA.

出版信息

Arch Intern Med. 1997 Nov 24;157(21):2453-8.

PMID:9385296
Abstract

Rifampin is a potent inducer of cytochrome P-450 oxidative enzymes. Examples of well-documented, clinically significant interactions include warfarin, oral contraceptives, cyclosporine, glucocorticoids, ketoconazole, theophylline, quinidine, digitoxin, and verapamil. Recent reports have demonstrated clinically relevant interactions with protease inhibitors, zidovudine, delavirdine, itraconazole, nifedipine, midazolam or triazolam, nortriptyline, and doxycycline. To avoid reduced therapeutic response, therapeutic failure, or toxic reactions when rifampin is added to or discontinued from medication regimens, clinicians need to be cognizant of these interactions. Enhanced knowledge of known interactions will continue to develop, including research on induction of specific cytochrome P-450 isoenzymes. New rifampin interactions will be discovered with further investigations.

摘要

利福平是一种强效的细胞色素P - 450氧化酶诱导剂。有充分文献记载的、具有临床意义的相互作用实例包括华法林、口服避孕药、环孢素、糖皮质激素、酮康唑、茶碱、奎尼丁、洋地黄毒苷和维拉帕米。最近的报告显示,利福平与蛋白酶抑制剂、齐多夫定、地拉韦啶、伊曲康唑、硝苯地平、咪达唑仑或三唑仑、去甲替林和强力霉素之间存在具有临床相关性的相互作用。为避免在用药方案中添加或停用利福平时出现治疗反应降低、治疗失败或毒性反应,临床医生需要了解这些相互作用。对已知相互作用的深入了解将不断发展,包括对特定细胞色素P - 450同工酶诱导作用的研究。随着进一步的研究,将会发现利福平的新的相互作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验